Vyne Therapeutics Stock Story
| VYNE Stock | USD 2.30 0.10 4.17% |
About 54% of Vyne Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Vyne Therapeutics suggests that many traders are impartial. Vyne Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Vyne Therapeutics. The current market sentiment, together with Vyne Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Vyne Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Vyne Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Vyne daily returns and investor perception about the current price of Vyne Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Vyne |
Requested story not found. it has been either deleted or moved. View all stories for Vyne Therapeutics.
Vyne Therapeutics Latest Timeline
Vyne Therapeutics is listed for 2.30. About 61.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.44. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vyne Therapeutics recorded a loss per share of 2.72. The entity had not issued any dividends in recent years. The firm had 1:18 split on the 13th of February 2023.Check out Vyne Therapeutics Hype Analysis, Vyne Therapeutics Correlation and Vyne Therapeutics Performance. For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Vyne Stock analysis
When running Vyne Therapeutics' price analysis, check to measure Vyne Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vyne Therapeutics is operating at the current time. Most of Vyne Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vyne Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vyne Therapeutics' price. Additionally, you may evaluate how the addition of Vyne Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is Vyne Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.72) | Revenue Per Share 0.041 | Quarterly Revenue Growth 11.667 | Return On Assets (0.26) | Return On Equity (0.46) |
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.